BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19244230)

  • 1. Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2'-O-Me-cAMP-AM.
    Chepurny OG; Leech CA; Kelley GG; Dzhura I; Dzhura E; Li X; Rindler MJ; Schwede F; Genieser HG; Holz GG
    J Biol Chem; 2009 Apr; 284(16):10728-36. PubMed ID: 19244230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans.
    Chepurny OG; Kelley GG; Dzhura I; Leech CA; Roe MW; Dzhura E; Li X; Schwede F; Genieser HG; Holz GG
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E622-33. PubMed ID: 20009023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase C-ε links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans.
    Dzhura I; Chepurny OG; Leech CA; Roe MW; Dzhura E; Xu X; Lu Y; Schwede F; Genieser HG; Smrcka AV; Holz GG
    Islets; 2011; 3(3):121-8. PubMed ID: 21478675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influx.
    Jarrard RE; Wang Y; Salyer AE; Pratt EP; Soderling IM; Guerra ML; Lange AM; Broderick HJ; Hockerman GH
    Mol Pharmacol; 2013 Jan; 83(1):191-205. PubMed ID: 23071106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.
    Roscioni SS; Kistemaker LE; Menzen MH; Elzinga CR; Gosens R; Halayko AJ; Meurs H; Schmidt M
    Respir Res; 2009 Sep; 10(1):88. PubMed ID: 19788733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells.
    Kang G; Chepurny OG; Malester B; Rindler MJ; Rehmann H; Bos JL; Schwede F; Coetzee WA; Holz GG
    J Physiol; 2006 Jun; 573(Pt 3):595-609. PubMed ID: 16613879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM.
    Kelley GG; Chepurny OG; Schwede F; Genieser HG; Leech CA; Roe MW; Li X; Dzhura I; Dzhura E; Afshari P; Holz GG
    Islets; 2009; 1(3):260-5. PubMed ID: 21099281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rap1 activation plays a regulatory role in pancreatic amylase secretion.
    Sabbatini ME; Chen X; Ernst SA; Williams JA
    J Biol Chem; 2008 Aug; 283(35):23884-94. PubMed ID: 18577515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic beta-cells and rat INS-1 cells.
    Kang G; Leech CA; Chepurny OG; Coetzee WA; Holz GG
    J Physiol; 2008 Mar; 586(5):1307-19. PubMed ID: 18202100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
    Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
    Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP signalling protects proximal tubular epithelial cells from cisplatin-induced apoptosis via activation of Epac.
    Qin Y; Stokman G; Yan K; Ramaiahgari S; Verbeek F; de Graauw M; van de Water B; Price LS
    Br J Pharmacol; 2012 Feb; 165(4b):1137-50. PubMed ID: 21745194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of Cav1.2 and Cav1.3-mediated glucose-stimulated insulin secretion by cAMP in INS-1 cells: distinct roles for exchange protein directly activated by cAMP 2 (Epac2) and protein kinase A.
    Liu G; Jacobo SM; Hilliard N; Hockerman GH
    J Pharmacol Exp Ther; 2006 Jul; 318(1):152-60. PubMed ID: 16565168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between cAMP signalling and sulfonylurea in insulin secretion.
    Shibasaki T; Takahashi T; Takahashi H; Seino S
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():118-25. PubMed ID: 25200305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells.
    Kang G; Joseph JW; Chepurny OG; Monaco M; Wheeler MB; Bos JL; Schwede F; Genieser HG; Holz GG
    J Biol Chem; 2003 Mar; 278(10):8279-85. PubMed ID: 12496249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EPAC activation inhibits acetaldehyde-induced activation and proliferation of hepatic stellate cell via Rap1.
    Yang Y; Yang F; Wu X; Lv X; Li J
    Can J Physiol Pharmacol; 2016 May; 94(5):498-507. PubMed ID: 26854595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epac1 mediates protein kinase A-independent mechanism of forskolin-activated intestinal chloride secretion.
    Hoque KM; Woodward OM; van Rossum DB; Zachos NC; Chen L; Leung GP; Guggino WB; Guggino SE; Tse CM
    J Gen Physiol; 2010 Jan; 135(1):43-58. PubMed ID: 20038525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of ß-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac.
    Leech CA; Dzhura I; Chepurny OG; Schwede F; Genieser HG; Holz GG
    Islets; 2010; 2(2):72-81. PubMed ID: 20428467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of Glucose-Stimulated Cdc42-Pak1 Activation and Insulin Secretion by a Selective Epac Activator in Type 2 Diabetic Human Islets.
    Veluthakal R; Chepurny OG; Leech CA; Schwede F; Holz GG; Thurmond DC
    Diabetes; 2018 Oct; 67(10):1999-2011. PubMed ID: 29986926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
    Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
    Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK.
    Eijkelkamp N; Wang H; Garza-Carbajal A; Willemen HL; Zwartkruis FJ; Wood JN; Dantzer R; Kelley KW; Heijnen CJ; Kavelaars A
    J Neurosci; 2010 Sep; 30(38):12806-15. PubMed ID: 20861385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.